Axoft secured $55M in Series A funding to advance clinical trials of its implantable brain-computer interface.
- Amount
- $55M
- Stage
- Series A
- Announced
- 29 April 2026
- Lead
- C.P. Group Innovation
- Other investors
- Alumni Ventures, Stanford President's Venture Fund, Hillhouse Investment, Gaorong Ventures
- Use of funds
- Expanding current clinical trials globally, progressing U.S. regulatory approval, and building a GMP manufacturing facility to mass produce iBCIs.
- Total raised
- $60M to date
- Checked
- Amount and date checked against the press source